Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines.

Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines.

Fuente:Bmc Complementary Medicine and Therapies

Extracto: This study highlights the potential of natural compounds in Shorea roxburghii in the development of more effective and safer anticancer agents as options for GIC as well as shedding light on new avenues for cancer treatment.

Claves:Anticancer, Antioxidant, Gastrointestinal cancer, Medicinal plant, Metabolic profiling-based screening

Cita:BMC Complement Med Ther 2024 Apr 30; 24 (1) : 178.

Autor/es:Janthamala, Sutthiwan (a)
Promraksa, Bundit (b)

institución:(a) Biomedical Sciences Program, Graduate School, Khon Kaen University, Khon Kaen, Thailand.
(b) Regional Medical Sciences Center 2 Phitsanulok, Department of Medical Sciences, Ministry of Public Health, Phitsanulok, Thailand.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12906-024-04479-1

Latent profiles of fatigue in inflammatory bowel disease.

Latent profiles of fatigue in inflammatory bowel disease.

Fuente:Bmc Gastroenterology

Extracto: Latent profile analysis identifies four classes of fatigue in an IBD cohort with associations with specific risk factors for fatigue along with specific IBD and demographic attributes. This has implications for the classification of fatigue in IBD and treatment algorithms.

Claves:Anxiety, Colitis, Depression, Fatigue, Inflammatory bowel disease, Mental health, Sleep quality

Cita:BMC Gastroenterol 2024 Apr 30; 24 (1) : 148.

Autor/es:Barnes, Alex (a)
Toson, Barbara (b)

institución:(a) Department of Gastroenterology, Southern Adelaide Local Health Network (SALHN), Flinders Medical Centre, Flinders Drive, Bedford Park, 5042, SA, Australia. alex.barnes@sa.gov.au.
(b) College of medicine and public health, Flinders University, Bedford Park, SA, Australia. alex.barnes@sa.gov.au.

Conflicto:Jane M Andrews: Speakers fees, and Ad Boards from: Abbott, AbbVie, Allergan, Anatara, AstraZeneca, Bayer, BMS 2020, Celegene, Celltrion, Falk, Ferring, Gilead, Hospira, Im-muninc, ImmunsanT, Janssen, MSD, Nestle, Novartis, Progen-ity, Pfizer, Sandoz, Shire, Takeda, Vifor, RAH research Fund, The Hospital Research Fund 2020-2022, The Helmsley Trust 2020-2023. Reme Mountifield: Speakers fees, and Ad Boards from: Abbott, AbbVie, Allergan, Anatara, AstraZeneca,... Bayer, BMS 2020, Celegene, Celltrion, Falk, Ferring, Gilead, Hospira, Im-muninc, ImmunsanT, Janssen, MSD, Nestle, Novartis, Progen-ity, Pfizer, Sandoz, Shire, Takeda. Rob V Bryant: has received Grant/Research support/Speaker fees (all paid to employer for research support): AbbVie, Ferring, Janssen, Shire, Takeda, Emerge Health; shareholder in BiomebankNo conflict of interest: Alex Barnes, Sutapa Mukherjee, Paul Spizzo, Barbara Toson.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12876-024-03239-2

Mycophenolate-induced colitis in a patient with lupus nephritis

Mycophenolate-induced colitis in a patient with lupus nephritis

Fuente:Journal of Medical Case Reports

Tipo de trabajo:Revisión

Extracto: The purpose of this paper is to report a case of early-onset MMF-induced colitis in a patient with lupus nephritis who had started MMF as induction therapy. A review of the available literature on this uncommon immunosuppressive effect is also presented.

Claves:Case report, Colitis, MMF, Mycophenolate mofetil

Cita:J Med Case Rep 2024 May 1; 18 (1) : 229.

Autor/es:Alakkas, Ziyad (a)
Gari, Abdulaziz M (b)

institución:(a) Rheumatology Unit, Internal Medicine Department, King Abdul-Aziz Specialist Hospital, Taif, Saudi Arabia. Alakkas.ziyad@gmail.com.
(b) Rheumatology Unit, Internal Medicine Department, King Fahad Hospital, Jeddah, Saudi Arabia.

Conflicto:The authors declare that there is no competing interests.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s13256-024-04539-7

Application and value of anxiety and depression scale in patients with functional dyspepsia.

Application and value of anxiety and depression scale in patients with functional dyspepsia.

Fuente:Bmc Psychology

Tipo de trabajo:Orientaciones y guía

Extracto: PHQ-9, SAS, HAMD, and HAMA scales have good application performance in FD patients. They can assist gastroenterologists in evaluating anxiety and depression symptoms, and provide reference and guidance for subsequent treatment.

Claves:Anxiety symptoms, Assessment, Depression symptoms, Functional disease, Functional dyspepsia

Cita:BMC Psychol 2024 Apr 30; 12 (1) : 244.

Autor/es:Ruan, Yejiao (a)
Lin, Hao (b)

institución:(a) The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, 1111 East Wenzhou Dadao, Longwan District, Wenzhou, 325000, Zhejiang, China.
(b) The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, 1111 East Wenzhou Dadao, Longwan District, Wenzhou, 325000, Zhejiang, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s40359-024-01744-3

Ability of Helicobacter pylori to internalize into Candida.

Ability of Helicobacter pylori to internalize into Candida.

Fuente:World Journal of Gastroenterology

Extracto: pylori into the stomach of humans.

Claves:Candida yeast, Helicobacter pylori, Helicobacter pylori transmission, Helicobacter pylori-specific gene, Intracellular presence

Cita:World J Gastroenterol 2024 Apr 28; 30 (16) : 2281-2284.

Autor/es:Chen, Zheng-Hong (a)
Sun, Jian-Chao (b)

institución:(a) Key Laboratory of Microbiology and Parasitology of Education Department of Guizhou, Guizhou Medical University, Guiyang 561113, Guizhou Province, China.
(b) Key Laboratory of Endemic and Ethnic Diseases of Ministry of Education, Guizhou Medical University, Guiyang 561113, Guizhou Province, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.3748/wjg.v30.i16.2281

Drug-induced mucosal alterations observed during esophagogastroduodenoscopy.

Fuente:World Journal of Gastroenterology

Extracto: This minireview aims to provide essential information on drug-induced mucosal alterations observed on esophagogastroduodenoscopy, along with representative endoscopic images.

Claves:Diagnosis, Duodenal lesions, Esophageal lesions, Esophagogastroduodenoscopy, Gastric lesions, Non-neoplastic lesions

Cita:World J Gastroenterol 2024 Apr 28; 30 (16) : 2220-2232.

Autor/es:Iwamuro, Masaya (a)
Kawano, Seiji (b)

institución:(a) Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan. pr145h2k@okayama-u.ac.jp.
(b) Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Conflicto:Conflict-of-interest statement: Iwamuro M has received lecture fees from Otsuka Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd., as well as grants from Taisho Pharmaceutical Co., Ltd., Zeria Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., and Abbott Japan Co., Ltd. Kawano S has received lecture fees from Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., AstraZeneca PLC,... Viatris Inc., Zeria Pharmaceutical Co., Ltd., and EA Pharma Co., Ltd., along with grants from Taisho Pharmaceutical Co., Ltd., Zeria Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., and Abbott Japan Co., Ltd. Otsuka M has received lecture fees from Chugai Pharmaceutical Co., Ltd., Gilead Sciences, Inc., Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, AbbVie GK, EA Pharma Co., Ltd., and Kowa Company, Ltd., along with grants from Taisho Pharmaceutical Co., Ltd., Zeria Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., and Abbott Japan Co., Ltd.

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.3748/wjg.v30.i16.2220

Fecal microbiota transplantation for irritable bowel syndrome: Current evidence and perspectives.

Fuente:World Journal of Gastroenterology

Extracto: At the same time, the application of FMT as a treatment for IBS confronts several challenges.

Claves:Fecal microbiota transplantation, Irritable bowel syndrome, Meta-analysis, Microbiota, Randomized controlled trial

Cita:World J Gastroenterol 2024 Apr 28; 30 (16) : 2179-2183.

Autor/es:Dai, Cong (a)
Huang, Yu-Hong (b)

institución:(a) Department of Gastroenterology, First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.
(b) Department of Gastroenterology, First Hospital of China Medical University, Shenyang 110001, Liaoning Province, China.

Conflicto:Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.3748/wjg.v30.i16.2179

Transjugular intrahepatic portosystemic shunt: A promising therapy for recompensation in cirrhotic patients.

Fuente:World Journal of Gastroenterology

Extracto: These results need to be validated in a larger prospective cohort.

Claves:Baveno VII, Cirrhosis recompensation, Portal pressure gradient, Predictor factor, Transjugular intrahepatic portosystemic shunt

Cita:World J Gastroenterol 2024 Apr 28; 30 (16) : 2285-2286.

Autor/es:Jin, Ya-Ni (a)
Zhang, Wei (b)

institución:(a) Department of Gastroenterology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210000, Jiangsu Province, China.
(b) Department of Gastroenterology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210000, Jiangsu Province, China. kimmysai@126.com.

Conflicto:Conflict-of-interest statement: All the authors declare that they have no competing interests.

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.3748/wjg.v30.i16.2285

MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?

Fuente:World Journal of Gastroenterology

Extracto: Discoveries regarding the influence of miRNAs on the inflammatory process and the exploration of their role in gene regulation are expected to provide a basis for the use of miRNAs not only as potent biomarkers in IBD but also as therapeutic targets for the control of inflammatory processes in personalized medicine.

Claves:Biomarker, Crohn’s disease, Inflammatory bowel disease, MicroRNAs, Therapy, Ulcerative colitis

Cita:World J Gastroenterol 2024 Apr 28; 30 (16) : 2184-2190.

Autor/es:de Oliveira, Ellen Cristina Souza (a)
Quaglio, Ana Elisa Valencise (b)

institución:(a) Department of Internal Medicine, Medical School, São Paulo State University (Unesp), Botucatu 18618-686, São Paulo, Brazil.
(b) Verum Ingredients, Botucatu Technology Park, Botucatu 18605-525, São Paulo, Brazil.

Conflicto:Conflict-of-interest statement: The authors report having no relevant conflicts of interest for this article.

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.3748/wjg.v30.i16.2184

Laryngopharyngeal reflux disease: Updated examination of mechanisms, pathophysiology, treatment, and association with gastroesophageal reflux disease.

Fuente:World Journal of Gastroenterology

Extracto: We also provide an in-depth exploration of the association between LPRD and gastroesophageal reflux disease.

Claves:Gastroesophageal reflux, Head neck surgery, Laryngitis, Laryngopharyngeal reflux, Otolaryngology

Cita:World J Gastroenterol 2024 Apr 28; 30 (16) : 2209-2219.

Autor/es:Cui, Na (a)
Dai, Ting (b)

institución:(a) Department of Otorhinolaryngology Head and Neck Surgery, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin Province, China.
(b) Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin Province, China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.3748/wjg.v30.i16.2209

Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer.

Fuente:World Journal of Gastroenterology

Extracto: Therefore, personalized treatments could be developed to maximize the advantages of immunotherapy.

Claves:Esophageal adenocarcinoma, Esophageal cancer, Esophageal squamous cell carcinoma, Immu-notherapy, Immunosuppression, Tumor immune microenvironment

Cita:World J Gastroenterol 2024 Apr 28; 30 (16) : 2195-2208.

Autor/es:Zhang, Xiao-Jun (a)
Yu, Yan (b)

institución:(a) Department of Clinical Laboratory, Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, Shaanxi Province, China.
(b) Department of Clinical Laboratory, Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, Shaanxi Province, China.

Conflicto:Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.3748/wjg.v30.i16.2195

Preoperative prediction of perineural invasion of rectal cancer based on a magnetic resonance imaging radiomics model: A dual-center study.

Fuente:World Journal of Gastroenterology

Extracto: The CR model based on preoperative MRI radiomics features and clinical risk factors can preoperatively predict the PNI status of RC noninvasively, which facilitates individualized treatment of RC patients.

Claves:Magnetic resonance imaging, Nomogram, Perineural invasion, Radiomics, Rectal cancer

Cita:World J Gastroenterol 2024 Apr 28; 30 (16) : 2233-2248.

Autor/es:Liu, Yan (a)
Sun, Bai-Jin-Tao (b)

institución:(a) Department of Radiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China.
(b) Department of Radiology, The Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, Sichuan Province, China.

Conflicto:Conflict-of-interest statement: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Formato:Informe impreso

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.3748/wjg.v30.i16.2233

Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis.

Evaluation of mucosal-associated invariant T-cells as a potential biomarker to predict infection risk in liver cirrhosis.

Fuente:Plos One

Tipo de trabajo:Revisión

Extracto: Relatively preserved MAIT cell levels in blood of patients with cirrhosis were associated with a somewhat higher risk of bacterial infections. The clinical relevance of this might not be strong. MAIT cells might however be an interesting biomarker to explore in future studies.

Cita:PLoS One 2024; 19 (5) : e0294695.

Autor/es:Bengtsson, Bonnie (a)
Maucourant, Christopher (b)

institución:(a) Department of Internal Medicine, Section of Gastroenterology, Södersjukhuset, Stockholm, Sweden.
(b) Unit of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Conflicto:HH reports research funding to his institution from Astra Zeneca, EchoSens, Gilead, Intercept, MSD, Novo Nordisk and Pfizer. Board advisory for BMS. All outside the current work. BB, CM, JKS, and NKB report no conflict of interest. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Formato:Informe virtual

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.1371/journal.pone.0294695

Functional dyspepsia: How to manage the burn and the bloat.

Functional dyspepsia: How to manage the burn and the bloat.

Fuente:Cleveland Clinic Journal of Medicine

Extracto: The authors discuss how to diagnose and treat both subtypes.

Cita:Cleve Clin J Med 2024 May 1; 91 (5) : 301-307.

Autor/es:Gabbard, Scott (a)
Vijayvargiya, Nina (b)

institución:(a) Department of Gastroenterology, Hepatology, and Nutrition, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH gabbars@ccf.org.
(b) Emory University, Atlanta, GA.

Formato:Informe virtual

Idioma:Inglés

País de fuente:EE.UU.

Sitio web:http://dx.doi.org/10.3949/ccjm.91a.23062

Risk factors for asthma-related hospital and intensive care admissions in children, adolescents and adults

Risk factors for asthma-related hospital and intensive care admissions in children, adolescents and adults

Fuente:Bmj Open Respiratory Research

Tipo de trabajo:Estudio de cohortes

Extracto: There are significant sociodemographic inequalities in the rates of asthma-related hospital and ICU admissions. Treating age-specific modifiable risk factors should be considered an integral part of asthma management, which could potentially reduce the rate of avoidable hospital admissions.

Claves:Asthma, Asthma Epidemiology

Cita:BMJ Open Respir Res 2024 May 1; 11 (1)

Autor/es:Simms-Williams, Nikita (a)
Nagakumar, Prasad (b)

institución:(a) University of Birmingham Institute of Applied Health Research, Birmingham, UK.
(b) Birmingham Women's and Children's Hospitals NHS Foundation Trust, Birmingham, UK p.nagakumar@bham.ac.uk.

Conflicto:Competing interests: SH reports receiving funding from NIHR and UKRI. KN has been awarded research grants from NIHR, UKRI/MRC, Kennedy Trust for Rheumatology Research, Health Data Research UK, Wellcome Trust, European Regional Development Fund, Institute for Global Innovation, Boehringer Ingelheim, Action Against Macular Degeneration Charity, Midlands Neuroscience Teaching and Development Funds, South Asian Health Foundation, Vifor Pharma, College of Police... and CSL Behring, with all payments made to his academic institution; KN received consulting fees from BI, Sanofi, CEGEDIM, MSD and holds a leadership/fiduciary role with NICST, a charity and OpenClinical, a Social Enterprise. AHM received personal and institution funds for talks, consultancy fees, education or research grants from GSK, AZ, Sanofi, Teva, BI, Novartis, Chiesi. NJA reports receiving funding from NIHR outside the submitted work. PN reports receiving grants from NIHR and fees for educational talks and consultancy from Novartis, GSK and Astrazaneca.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1136/bmjresp-2023-001746

Comorbidity and multimorbidity in patients with cirrhosis, hospitalised in an internal medicine ward: a monocentric, cross-sectional study.

Comorbidity and multimorbidity in patients with cirrhosis, hospitalised in an internal medicine ward: a monocentric, cross-sectional study.

Fuente:Bmj Open

Extracto: Comorbidity is more common in alcohol cirrhosis compared with other aetiologies in a hospital, internal medicine setting.

Claves:Adult gastroenterology, Aging, Hepatobiliary disease

Cita:BMJ Open 2024 May 1; 14 (5) : e077576.

Autor/es:Lenti, Marco Vincenzo (a)
Ballesio, Alessia (b)

institución:(a) Department of Internal Medicine and Medical Therapeutics, University of Pavia, Pavia, Italy.
(b) Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1136/bmjopen-2023-077576

A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis.

A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis.

Fuente:Nature Communications

Extracto: These findings suggest that differences in mitochondrial bioenergetics and lipid droplet formation are intrinsic to AC hepatocytes and can play a role in its pathogenesis.

Cita:Nat Commun 2024 May 1; 15 (1) : 2869.

Autor/es:Mukhopadhyay, Bani (a)
Marietta, Cheryl (b)

institución:(a) Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, 20892, USA.
(b) Laboratory of Neurogenetics, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD, 20892, USA.

Conflicto:The authors do not have any financial and non-financial interest in design or preparation of the manuscript. D.M. receives a salary from Leica Microsystems where he is Manager for Aivia Software, however received no compensation to assist for this manuscript. A.J.S. have stock options in Genfit, Akarna, Tiziana, Durect Inversago, and Galmed. He has served as a consultant to Astra... Zeneca, Salix, Tobira, Takeda, Jannsen, Gilead, Terns, Birdrock, Merck, Valeant, Boehringer Ingelheim, Bristol Myers Squibb, Lilly, Hemoshear, Novartis, Novo Nordisk, Pfizer, 89 bio, Regeneron, Alnylam, Akero, Tern, Histoindex, Corcept, Poxel, Path AI, and Genfit. His institution has received grant support from Gilead, Salix, Tobira, Bristol Myers, Shire, Intercept, Merck, Astra Zeneca, Malinckrodt and Novartis. He receives royalties from Elsevier and UptoDate. However, A.J.S. received no compensation from any source for this manuscript.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1038/s41467-024-47085-y

Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.

Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.

Fuente:Clinical and Experimental Medicine

Extracto: These findings suggest that LOXL1-AS1 may be both a reliable biomarker and a potential therapeutic target for cancers.

Claves:Biomarker, Cancer, LOXL1-AS1, Long non-coding RNA, Therapeutic target

Cita:Clin Exp Med 2024 May 2; 24 (1) : 93.

Autor/es:Fu, Xiao-Ping (a)
Ji, Chun-Yan (b)

institución:(a) Department of Health Management Center, Hubei Provincial Hospital of Traditional Chinese Medicine, Hongshan District, 856 Luoyu Road, Wuhan, 430070, People's Republic of China.
(b) Department of Gastroenterology, Hubei Provincial Hospital of Traditional Chinese and Western Medicine, Wuhan, 430015, People's Republic of China.

Conflicto:Los autores declaran no tener conflictos de interés con la investigación

Formato:Informe virtual

Idioma:Inglés

País de fuente:Italia

Sitio web:http://dx.doi.org/10.1007/s10238-024-01355-7

Sexual and gender minority content in undergraduate medical education in the United States and Canada: current state and changes since 2011.

Sexual and gender minority content in undergraduate medical education in the United States and Canada: current state and changes since 2011.

Fuente:Bmc Medical Education

Extracto: Compared to a 2011 study, the median reported time dedicated to LGBTQI + health-related topics in 2022 increased across US and Canadian UME institutions, but the breadth, efficacy, or quality of instruction continued to vary substantially. Despite the increased hours, this still falls short of the number of hours based on recommended LGBTQI + health competencies from the Association of American Medical Colleges. While most deans of medical education reported their institutions' coverage of LGBTQI + health as 'fair,' 'good,' or 'very good,' there continues to be a call from UME leadership to increase curricular content. This requires dedicated training for faculty and students.

Claves:LGBTQ persons, Undergraduate medical education

Cita:BMC Med Educ 2024 May 1; 24 (1) : 482.

Autor/es:Streed, Carl G Jr (a)
Michals, Amy (b)

institución:(a) Section of General Internal Medicine, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, 801 Massachusetts Ave., Room 2082, Boston, MA, 02118, USA. Carl.Streed@bmc.org.
(b) GenderCare Center, Boston Medical Center, Boston, MA, USA. Carl.Streed@bmc.org.

Conflicto:Dr. Streed received consultation fees from EverlyWell, L’Oreal, the Research Institute for Gender Therapeutics, and the Texas Health Institute on topics unrelated to this work. Dr. Obedin-Maliver received consultation fees from Ibis Reproductive Health, Hims Inc., Folx Health Inc., and Sage Therapeutics on topics unrelated to this work. Dr. Lunn received consultation fees from Hims Inc., Folx Health Inc., Otsuka... ka Pharmaceutical Development and Commercialization, Inc., and the American Dental Association on topics unrelated to this work.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12909-024-05469-0

Campylobacter jejuni virulence factors: update on emerging issues and trends.

Fuente:Journal of Biomedical Science

Extracto: jejuni will enable future development of effective preventative approaches and vaccines against this pathogen.

Claves:Campylobacter jejuni, Biofilm, Chemotaxis, Pathogenesis, Polysaccharide capsule, Vaccine

Cita:J Biomed Sci 2024 May 1; 31 (1) : 45.

Autor/es:Tikhomirova, Alexandra (a)
McNabb, Emmylee R (b)

institución:(a) Biomedicine Discovery Institute, Department of Microbiology, Monash University, Melbourne, VIC, 3800, Australia.
(b) Biomedicine Discovery Institute, Department of Microbiology, Monash University, Melbourne, VIC, 3800, Australia.

Conflicto:Authors declare no competing interest.

Formato:Informe virtual

Idioma:Inglés

País de fuente:Reino Unido

Sitio web:http://dx.doi.org/10.1186/s12929-024-01033-6